165 related articles for article (PubMed ID: 23831656)
1. [A case of liver and bone metastases after complete resection of gastric GIST effectively treated with radiotherapy and imatinib mesylate].
Fujisawa T; Matsumoto Y; Nishizawa A; Takata M
Nihon Shokakibyo Gakkai Zasshi; 2013 Jul; 110(7):1258-64. PubMed ID: 23831656
[TBL] [Abstract][Full Text] [Related]
2. [A case of gastrointestinal stromal tumor with liver and bone metastases effectively treated with radiofrequency ablation and imatinib mesylate].
Ishikawa A; Teratani T; Ono S; Ochiai T; Kakinoki N; Kishimoto Y; Kamoshida T; Hirai S; Oka Y; Shimokama T
Nihon Shokakibyo Gakkai Zasshi; 2006 Nov; 103(11):1274-9. PubMed ID: 17085910
[TBL] [Abstract][Full Text] [Related]
3. [A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib].
Murakami M; Ebisui C; Okada K; Okamura S; Murata K; Nakagomi N; Tamai M; Kinuta M
Gan To Kagaku Ryoho; 2014 Jan; 41(1):99-101. PubMed ID: 24423961
[TBL] [Abstract][Full Text] [Related]
4. Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
Colović R; Micev M; Matić S; Colović N; Grubor N; Atkinson HD
Vojnosanit Pregl; 2013 Feb; 70(2):225-8. PubMed ID: 23607193
[TBL] [Abstract][Full Text] [Related]
5. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
Shen C; Chen H; Yin Y; Chen J; Zhang B; Chen Z; Chen J
Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
[TBL] [Abstract][Full Text] [Related]
6. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
Zheng S; Jia J; Pan YL; Tao DY; Lu HS
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
[No Abstract] [Full Text] [Related]
7. Imatinib mesylate induces responses in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy.
Fiorentini G; Bernardeschi P; Rossi S; Dentico P; Biancalani M; Giustarini G; Turrisi G
J Cancer Res Ther; 2006; 2(2):68-71. PubMed ID: 17998678
[TBL] [Abstract][Full Text] [Related]
8. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
[TBL] [Abstract][Full Text] [Related]
9. Management of gastrointestinal stromal tumors: looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy.
Pandey R; Kochar R
J Gastrointest Cancer; 2012 Dec; 43(4):547-52. PubMed ID: 22847491
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
Zhang L; Cai M; Deng J; Wang X; Wang B; Liu N; Pan Y; Zhang R; Cui Q; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):331-4. PubMed ID: 24760639
[TBL] [Abstract][Full Text] [Related]
11. [Three cases of gastrointestinal stromal tumor (GIST) with bone metastasis].
Nakajima T; Miwa S; Ando T; Yamada K; Miyazaki T; Hosokawa A; Kudo T; Nozawa H; Maeda K; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):836-40. PubMed ID: 18525190
[TBL] [Abstract][Full Text] [Related]
12. Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy.
Melichar B; Voboril Z; Nozicka J; Ryska A; Urminská H; Vanecek T; Michal M
Intern Med; 2005 Nov; 44(11):1163-8. PubMed ID: 16357454
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Survival After Multidisciplinary Treatment Including Surgery for Metachronous Metastases of Small Intestinal Gastrointestinal Stromal Tumors after Curative Resection: A Case Report.
Katayanagi S; Yokoyama T; Makuuchi Y; Osakabe H; Iwamoto H; Sumi T; Hirano H; Katsumata K; Tsuchida A; Hirota S; Kawachi S
Am J Case Rep; 2019 Dec; 20():1942-1948. PubMed ID: 31875847
[TBL] [Abstract][Full Text] [Related]
14. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
15. Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestinal stromal tumor after treatment with imatinib mesylate.
Suzuki S; Sasajima K; Miyamoto M; Watanabe H; Yokoyama T; Maruyama H; Matsutani T; Liu A; Hosone M; Maeda S; Tajiri T
World J Gastroenterol; 2008 Jun; 14(23):3763-7. PubMed ID: 18595147
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of gastrointestinal stromal tumours: a single centre experience during the past 17 years.
De Vogelaere K; Van De Winkel N; Aerts M; Haentjens P; Spitali C; Van Loo I; Delvaux G
Acta Chir Belg; 2014; 114(3):167-73. PubMed ID: 25102705
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
[TBL] [Abstract][Full Text] [Related]
18. [Curative resection for bulky gastrointestinal stromal tumor with conversion therapy by imatinib].
Nishimura T; Sakata K; Maeda Y; Nagashima Y; Okada T; Nakamura M; Setoguchi M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2202-4. PubMed ID: 22202330
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of primary unresectable and/or recurrent gastrointestinal stromal tumors of small intestine presenting hemoperitoneum caused by administration of imatinib mesylate].
Yokoyama A; Dairaku N; Kusano M; Koshita S; Shimada N; Yamagiwa T; Kojima Y; Ojima T; Ikeya S; Nakayama H; Sugai Y; Hiwatashi N; Asano S
Nihon Shokakibyo Gakkai Zasshi; 2008 Nov; 105(11):1619-26. PubMed ID: 18987447
[TBL] [Abstract][Full Text] [Related]
20. [A case of recurrent gastrointestinal stromal tumor progressing after interruption of long-term imatinib therapy].
Nakatsuka R; Takahashi T; Miyazaki Y; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2478-80. PubMed ID: 25731563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]